These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 31726199)
1. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment. Jana A; Narula P; Chugh A; Kulshreshtha R Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis. Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242 [TBL] [Abstract][Full Text] [Related]
3. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
4. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
5. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
6. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells. Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389 [TBL] [Abstract][Full Text] [Related]
7. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]
8. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX; Yang Y; Zhang X; Luan XP Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350 [TBL] [Abstract][Full Text] [Related]
9. Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity. Doan P; Nguyen P; Murugesan A; Candeias NR; Yli-Harja O; Kandhavelu M Cells; 2021 Aug; 10(8):. PubMed ID: 34440745 [TBL] [Abstract][Full Text] [Related]
10. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T; Mingyi M; Qiu X; Qiu Y Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
13. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma. Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin. Yang CH; Wang Y; Sims M; Cai C; Pfeffer LM Cancer Lett; 2019 Nov; 465():59-67. PubMed ID: 31491450 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Shang C; Tang W; Pan C; Hu X; Hong Y Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407 [TBL] [Abstract][Full Text] [Related]
16. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841 [TBL] [Abstract][Full Text] [Related]
18. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells. C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939 [TBL] [Abstract][Full Text] [Related]
19. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
20. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. Li Y; Liu Y; Ren J; Deng S; Yi G; Guo M; Shu S; Zhao L; Peng Y; Qi S J Neurooncol; 2018 Jul; 138(3):499-508. PubMed ID: 29876787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]